Scios Natrecor Physician Education Should Address Hypotension Risk
Executive Summary
Scios' Natrecor physician education program should highlight the potential for symptomatic hypotension with the decompensated congestive heart failure treatment, FDA's Cardiovascular & Renal Drugs Advisory Committee said May 25.